Pittenger & Anderson Inc. Grows Position in Zoetis Inc. $ZTS

Key Points

• Pittenger & Anderson Inc. has increased its stake in Zoetis Inc. by 4.8% to a total of 124,335 shares, valued at approximately $19.39 million.
• Zoetis has seen varied analyst ratings, with UBS and Leerink Partners downgrading their recommendations, while Argus maintains a "buy" rating with a target price of $190.00.
• The company recently announced a quarterly dividend of $0.50, representing an annualized dividend yield of 1.4%, with a payout ratio of 34.42%.

Pittenger & Anderson Inc. grew its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 4.8% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 124,335 shares of the company's stock after purchasing an additional 5,685 shares during the quarter. Pittenger & Anderson Inc.'s holdings in Zoetis were worth $19,390,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Nova Wealth Management Inc. purchased a new stake in shares of Zoetis during the first quarter valued at approximately $25,000. 1248 Management LLC purchased a new stake in shares of Zoetis during the first quarter valued at approximately $27,000. Saudi Central Bank bought a new position in shares of Zoetis during the first quarter valued at approximately $29,000. Cornerstone Planning Group LLC raised its holdings in shares of Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company's stock valued at $30,000 after acquiring an additional 88 shares in the last quarter. Finally, REAP Financial Group LLC raised its holdings in shares of Zoetis by 201.5% during the second quarter. REAP Financial Group LLC now owns 196 shares of the company's stock valued at $31,000 after acquiring an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company's stock.

Analysts Set New Price Targets

ZTS has been the subject of a number of recent analyst reports. UBS Group decreased their target price on Zoetis from $165.00 to $158.00 and set a "neutral" rating for the company in a report on Monday. Leerink Partnrs downgraded Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. Argus restated a "buy" rating and set a $190.00 target price on shares of Zoetis in a report on Tuesday, September 9th. Leerink Partners downgraded Zoetis from an "outperform" rating to a "market perform" rating and decreased their target price for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of Zoetis in a report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, Zoetis presently has an average rating of "Hold" and an average price target of $195.00.

Zoetis Price Performance

Shares of ZTS stock opened at $145.11 on Tuesday. The stock has a market cap of $64.31 billion, a price-to-earnings ratio of 24.98, a PEG ratio of 2.31 and a beta of 0.90. The business's fifty day moving average is $148.65 and its 200 day moving average is $153.60. Zoetis Inc. has a twelve month low of $139.34 and a twelve month high of $193.00. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.14. The company had revenue of $2.46 billion for the quarter, compared to analysts' expectations of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.56 earnings per share. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Research analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Stockholders of record on Friday, October 31st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, October 31st. Zoetis's dividend payout ratio is currently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.